Skip to main content
. 2023 Mar 24;10(3):e01018. doi: 10.14309/crj.0000000000001018

Figure 1.

Figure 1.

Computed tomography evidence of acute pancreatitis attributed to pembrolizumab use. New diffuse pancreatic enlargement (white arrow) and adjacent fat stranding are visualized.